139 related articles for article (PubMed ID: 29348651)
1. Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.
Kuypers KPC; de la Torre R; Farre M; Xicota L; de Sousa Fernandes Perna EB; Theunissen EL; Ramaekers JG
Sci Rep; 2018 Jan; 8(1):1061. PubMed ID: 29348651
[TBL] [Abstract][Full Text] [Related]
2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
3. 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
Martín-Santos R; Torrens M; Poudevida S; Langohr K; Cuyás E; Pacifici R; Farré M; Pichini S; de la Torre R
Addict Biol; 2010 Jan; 15(1):15-22. PubMed ID: 19878141
[TBL] [Abstract][Full Text] [Related]
4. Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.
Yubero-Lahoz S; Kuypers KP; Ramaekers JG; Langohr K; Farré M; de la Torre R
Psychopharmacology (Berl); 2015 Jun; 232(11):1921-9. PubMed ID: 25524139
[TBL] [Abstract][Full Text] [Related]
5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
6. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).
Pardo-Lozano R; Farré M; Yubero-Lahoz S; O'Mathúna B; Torrens M; Mustata C; Pérez-Mañá C; Langohr K; Cuyàs E; Carbó Ml; de la Torre R
PLoS One; 2012; 7(10):e47599. PubMed ID: 23112822
[TBL] [Abstract][Full Text] [Related]
8. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
Guillot C
J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
[TBL] [Abstract][Full Text] [Related]
9. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.
Roiser JP; Rogers RD; Cook LJ; Sahakian BJ
Psychopharmacology (Berl); 2006 Oct; 188(2):213-27. PubMed ID: 16941121
[TBL] [Abstract][Full Text] [Related]
10. Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects.
Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME
ACS Chem Neurosci; 2019 Jul; 10(7):3120-3131. PubMed ID: 30589533
[TBL] [Abstract][Full Text] [Related]
11. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily life: a daily process approach to gene-environment interaction.
Gunthert KC; Conner TS; Armeli S; Tennen H; Covault J; Kranzler HR
Psychosom Med; 2007 Nov; 69(8):762-8. PubMed ID: 17942837
[TBL] [Abstract][Full Text] [Related]
13. Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
Potter A; Downey L; Stough C
Curr Drug Abuse Rev; 2013 Mar; 6(1):71-6. PubMed ID: 23259912
[TBL] [Abstract][Full Text] [Related]
14. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.
de Win MM; Reneman L; Reitsma JB; den Heeten GJ; Booij J; van den Brink W
Psychopharmacology (Berl); 2004 May; 173(3-4):376-82. PubMed ID: 14726997
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
Allott K; Canny BK; Broadbear JH; Stepto NK; Murphy B; Redman J
J Psychopharmacol; 2009 Sep; 23(7):759-74. PubMed ID: 18562414
[TBL] [Abstract][Full Text] [Related]
16. Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
Scott RM; Hides L; Allen JS; Burke R; Lubman DI
Psychopharmacology (Berl); 2010 Mar; 209(1):25-36. PubMed ID: 20101393
[TBL] [Abstract][Full Text] [Related]
17. Decreased pain tolerance and mood in recreational users of MDMA.
O'Regan MC; Clow A
Psychopharmacology (Berl); 2004 May; 173(3-4):446-51. PubMed ID: 14752588
[TBL] [Abstract][Full Text] [Related]
18. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.
Verheyden SL; Hadfield J; Calin T; Curran HV
Psychopharmacology (Berl); 2002 Apr; 161(1):23-31. PubMed ID: 11967627
[TBL] [Abstract][Full Text] [Related]
19. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users.
Curran HV; Rees H; Hoare T; Hoshi R; Bond A
Psychopharmacology (Berl); 2004 May; 173(3-4):425-33. PubMed ID: 14735288
[TBL] [Abstract][Full Text] [Related]
20. Chronic MDMA (ecstasy) use, cognition and mood.
McCardle K; Luebbers S; Carter JD; Croft RJ; Stough C
Psychopharmacology (Berl); 2004 May; 173(3-4):434-9. PubMed ID: 15088077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
